相关实验视频

Updated: Jan 11, 2026

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

通过人类iNKT-DC合物获得CD8+ T细胞抗瘤免疫力

Dana C Baiu¹, Kelsey A Smith¹, Sarah A Ferguson¹

¹University of Wisconsin-Madison, Madison, WI, United States.

Cancer immunology research

|November 14, 2025

概括

不变的自然杀手T (iNKT) 细胞与树突细胞 (DC) 配对形成强大的细胞免疫疗法复合体. 这些iNKT-DC复合体有效地激活CD8+T细胞,并减少侵袭性B细胞淋巴瘤瘤.

科学领域:

免疫学免疫学免疫学
细胞生物学细胞生物学
癌症研究癌症研究

背景情况:

不变的自然杀手T (iNKT) 细胞通过与树突细胞 (DC) 相互作用来放大免疫反应.
对于iNKT细胞辅助的精确机制尚不完全理解.
了解iNKT-DC相互作用对于开发新型免疫疗法至关重要.

研究的目的:

研究iNKT细胞-DC复合体的形成和功能.
在癌症模型中评估iNKT-DC复合物的治疗潜力.
阐明iNKT-DC介导的抗瘤免疫的基础分子机制.

主要方法:

形成和表征全基CD4+iNKT细胞单细胞衍生的DC双细胞复合体.
对DC表面分子表达和信号的分析.
通过iNKT-DC复合体对CD8+T细胞激活的评估.
使用人类B细胞淋巴瘤异种移植模型的体内疗效研究.
评估iNKT-DC复合体在头部和部癌症患者衍生的DCs.

主要成果:

全基性CD4+iNKT细胞与单细胞衍生的DC形成稳定的复合体,增强DC信号传递.
iNKT-DC复合体表现出明显的共刺激特征,包括DC上MHC类I,4-1BBL,OX40L和IL-15Rα的升高,以及iNKT细胞上的CD70.
这些复合物强烈地激活CD8+ T细胞.
在体内给予iNKT-DC复合物导致显著的瘤减少,抗原特异性B细胞清除,并在淋巴瘤模型中增强T细胞反应.
iNKT-DC免疫疗法在晚期,免疫检查点阻塞耐药瘤中表现出有效性,并且在头癌患者衍生的DC中表现出有希望.

结论:

单细胞衍生的DC与异性CD4+iNKT细胞配对形成一种强大的细胞免疫疗法.
iNKT-DC复合体激活抗原特异性CD8+T细胞免疫力,使已耗尽的抗瘤反应复苏.
这种方法对治疗攻击性癌症,包括B细胞淋巴瘤和头癌具有重大潜力.

更多相关视频

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...